| scholarly article | Q13442814 |
| P2093 | author name string | C Peter Verrijzer | |
| Marcin M Gorski | |||
| Sima Kheradmand Kia | |||
| Stavros Giannakopoulos | |||
| P2860 | cites work | Translating the Histone Code | Q22065840 |
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers | Q24534231 | ||
| The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells | Q24680814 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2 | Q28181639 | ||
| UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development | Q28241669 | ||
| Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer | Q28277002 | ||
| Polycomb silencing mechanisms and the management of genomic programmes | Q28279277 | ||
| The epigenomics of cancer | Q28289975 | ||
| Genome regulation by polycomb and trithorax proteins | Q28289984 | ||
| Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors | Q28294240 | ||
| Epigenetics: a landscape takes shape | Q29616623 | ||
| The epigenetic progenitor origin of human cancer | Q29617486 | ||
| Polycomb silencers control cell fate, development and cancer | Q29619697 | ||
| The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus | Q29619815 | ||
| Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer | Q29622925 | ||
| Stabilization of chromatin structure by PRC1, a Polycomb complex | Q33868583 | ||
| Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. | Q34202062 | ||
| SWI/SNF chromatin remodeling and cancer | Q34493162 | ||
| On the use of the word 'epigenetic'. | Q34615615 | ||
| Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination | Q34673352 | ||
| pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. | Q35565308 | ||
| The SWI/SNF complex--chromatin and cancer. | Q35667471 | ||
| ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia | Q35670201 | ||
| Polycomb response elements and targeting of Polycomb group proteins in Drosophila. | Q36567949 | ||
| Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. | Q36572080 | ||
| Polycomb/Trithorax response elements and epigenetic memory of cell identity | Q36690774 | ||
| Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis. | Q38310616 | ||
| Functional differentiation of SWI/SNF remodelers in transcription and cell cycle control | Q40208956 | ||
| Oncogenic activity of Cdc6 through repression of the INK4/ARF locus | Q40298342 | ||
| Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. | Q40446274 | ||
| Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes | Q40584373 | ||
| P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells | Q40618783 | ||
| Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins | Q41912236 | ||
| Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors | Q43867083 | ||
| CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. | Q43948180 | ||
| Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. | Q44083876 | ||
| Polycomb complexes and the propagation of the methylation mark at the Drosophila ubx gene. | Q52010804 | ||
| Senescence comes of age | Q57580244 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3457-3464 | |
| P577 | publication date | 2008-03-10 | |
| P1433 | published in | Molecular and Cellular Biology | Q3319478 |
| P1476 | title | SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus | |
| P478 | volume | 28 |
| Q36394208 | A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro |
| Q38692678 | ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers |
| Q57167864 | ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response? |
| Q26849467 | ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy |
| Q34627244 | ATP-dependent chromatin remodeling: genetics, genomics and mechanisms |
| Q79790429 | An INKlination for epigenetic control of senescence |
| Q57306913 | An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures |
| Q50981168 | Antisense noncoding RNA promoter regulates the timing of de novo methylation of an imprinting control region. |
| Q36893203 | Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies |
| Q34298075 | BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression |
| Q36759676 | BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss |
| Q36788045 | BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene. |
| Q99594988 | COMPASS and SWI/SNF complexes in development and disease |
| Q24629853 | Cellular senescence and tumor suppressor gene p16 |
| Q38261746 | Chromatin remodeler mutations in human cancers: epigenetic implications |
| Q37810688 | Chromatin: a molecular interface between cancer and aging |
| Q92702721 | Components from the Human c-myb Transcriptional Regulation System Reactivate Epigenetically Repressed Transgenes |
| Q28067573 | Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression |
| Q95407636 | Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer |
| Q42109237 | DDB1-CUL4 and MLL1 mediate oncogene-induced p16INK4a activation |
| Q42558928 | DPY30 regulates pathways in cellular senescence through ID protein expression |
| Q92254227 | Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer |
| Q51116901 | Deciphering Subunit-Specific Functions within SWI/SNF Complexes. |
| Q48186642 | Disruption of mammalian SWI/SNF and Polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities. |
| Q48262529 | Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers. |
| Q96137365 | Dose-dependent functions of SWI/SNF BAF in permitting and inhibiting cell proliferation in vivo |
| Q50733282 | Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a. |
| Q38639828 | Driver mutations of cancer epigenomes. |
| Q36835530 | Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2. |
| Q41902469 | Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states |
| Q34541488 | EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer |
| Q59795355 | EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers |
| Q39433602 | EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. |
| Q55106988 | Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties. |
| Q34213023 | Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation |
| Q34460981 | Epigenetic control of aging |
| Q21245250 | Epigenetic regulation of caloric restriction in aging |
| Q24604190 | Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health |
| Q33604848 | Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. |
| Q37841191 | Epigenetic silencing of tumor suppressor genes in pancreatic cancer |
| Q90569909 | Epigenetic synthetic lethality approaches in cancer therapy |
| Q38709544 | Epigenomic regulation of oncogenesis by chromatin remodeling |
| Q34549944 | Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression |
| Q36707535 | Establishment and characterization of MRT cell lines from genetically engineered mouse models and the influence of genetic background on their development. |
| Q36956610 | Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs. |
| Q27027021 | Extracranial rhabdoid tumours: what we have learned so far and future directions |
| Q38217345 | Functional genomics of the 9p21.3 locus for atherosclerosis: clarity or confusion? |
| Q30528506 | Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart |
| Q90243494 | G-tract RNA removes Polycomb repressive complex 2 from genes |
| Q36870334 | Gene silencing and Polycomb group proteins: an overview of their structure, mechanisms and phylogenetics |
| Q37835825 | Gene silencing by the Polycomb group proteins and associations with cancer |
| Q26765438 | Genetics and biology of pancreatic ductal adenocarcinoma |
| Q37392280 | Genome-Wide Profiles of Extra-cranial Malignant Rhabdoid Tumors Reveal Heterogeneity and Dysregulated Developmental Pathways. |
| Q38906678 | H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer |
| Q24657459 | Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS |
| Q35510392 | Histone methylases as novel drug targets: developing inhibitors of EZH2. |
| Q100739232 | Immune responses in genomically simple SWI/SNF-deficient cancers |
| Q34998257 | Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9 |
| Q31111648 | Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines |
| Q91259756 | Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer |
| Q50284000 | Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B. |
| Q24632383 | Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene |
| Q39949572 | Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. |
| Q41811052 | MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells |
| Q38961785 | Maintaining cell identity: PRC2-mediated regulation of transcription and cancer |
| Q39229171 | Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities |
| Q38747872 | Marked for death: targeting epigenetic changes in cancer |
| Q39312199 | Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes |
| Q93039110 | Modeling medulloblastoma in vivo and with human cerebellar organoids |
| Q37962015 | Modulation of gene expression in ovarian cancer by active and repressive histone marks |
| Q26770685 | Molecular mechanisms of long noncoding RNAs on gastric cancer |
| Q42416688 | Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer--mechanisms and potential therapeutic insights. |
| Q92962287 | NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors |
| Q37785984 | Nucleosome dynamics and epigenetic stability. |
| Q37122320 | Nucleosome remodeling and epigenetics. |
| Q38122565 | PBRM1 and BAP1 as novel targets for renal cell carcinoma |
| Q38844565 | PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311. |
| Q90261560 | Particulate matter-induced senescence of skin keratinocytes involves oxidative stress-dependent epigenetic modifications |
| Q43126163 | Pediatric rhabdoid tumors of kidney and brain show many differences in gene expression but share dysregulation of cell cycle and epigenetic effector genes |
| Q37629613 | Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer |
| Q38283093 | Polycomb group proteins--epigenetic repressors with emerging roles in melanocytes and melanoma |
| Q92877957 | Polycomb/Trithorax Antagonism: Cellular Memory in Stem Cell Fate and Function |
| Q34342958 | Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. |
| Q37309123 | Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. |
| Q42917409 | Real-time in vivo imaging of p16gene expression: a new approach to study senescence stress signaling in living animals |
| Q33699134 | Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism |
| Q37545071 | Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development |
| Q38028793 | Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers |
| Q24337483 | Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma |
| Q33844721 | Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets |
| Q38083797 | Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer |
| Q37187733 | Role of EZH2 histone methyltrasferase in melanoma progression and metastasis |
| Q38906194 | Role of the Polycomb Repressive Complex 2 (PRC2) in Transcriptional Regulation and Cancer |
| Q37924588 | Roles of the Polycomb group proteins in stem cells and cancer |
| Q47748373 | SMARCB1 is required for widespread BAF complex-mediated activation of enhancers and bivalent promoters |
| Q35125250 | SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters |
| Q38953852 | SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression. |
| Q35176127 | SWI/SNF complexes are required for full activation of the DNA-damage response |
| Q37886668 | SWI/SNF nucleosome remodellers and cancer. |
| Q36163245 | SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer |
| Q28269618 | SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2 |
| Q35592205 | SWItching on the transcriptional circuitry in melanoma |
| Q38081391 | Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics |
| Q35545894 | Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression |
| Q24317899 | Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus |
| Q33805966 | Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. |
| Q37725658 | Soft skills turned into hard facts: nucleosome remodelling at developmental switches. |
| Q38567366 | Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer |
| Q28087134 | Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy |
| Q35369863 | TCR-dependent transformation of mature memory phenotype T cells in mice |
| Q36445523 | Targeting EZH2 and PRC2 dependence as novel anticancer therapy |
| Q26769027 | Targeting EZH2 in cancer |
| Q35006903 | The Arabidopsis SWI2/SNF2 chromatin Remodeler BRAHMA regulates polycomb function during vegetative development and directly activates the flowering repressor gene SVP. |
| Q34170839 | The BRG1 chromatin remodeler protects against ovarian cysts, uterine tumors, and mammary tumors in a lineage-specific manner |
| Q38896059 | The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer |
| Q39454240 | The Role of p16INK4a Pathway in Human Epidermal Stem Cell Self-Renewal, Aging and Cancer |
| Q88964948 | The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma |
| Q36384268 | The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma |
| Q34038585 | The molecular balancing act of p16(INK4a) in cancer and aging |
| Q34440758 | The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors. |
| Q37420245 | The role of SMARCB1/INI1 in development of rhabdoid tumor. |
| Q38184514 | The role of long noncoding RNAs in the epigenetic control of gene expression. |
| Q37600120 | The stem cell--chromatin connection. |
| Q37791830 | Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins |
| Q33933332 | Tissue-specific p19Arf regulation dictates the response to oncogenic K-ras |
| Q37850681 | Transcriptional regulation of cellular senescence |
| Q34235226 | Trithorax group proteins: switching genes on and keeping them active |
| Q47823236 | Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinoma. |
| Q38856913 | Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma |
| Q37122890 | Variable requirements for DNA-binding proteins at polycomb-dependent repressive regions in human HOX clusters |
| Q38247363 | Vulnerabilities of mutant SWI/SNF complexes in cancer. |
| Q39325305 | ZRF1 controls oncogene-induced senescence through the INK4-ARF locus |
| Q35163529 | esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function |
| Q35051176 | βTrCP regulates BMI1 protein turnover via ubiquitination and degradation. |
Search more.